(Total Views: 501)
Posted On: 08/17/2019 6:38:48 AM
Post# of 154867
We on this board have become conversant about CCR5's effect on cancer, the positives of blocking it and leronlimab's very good likelihood of success.
Converting any of the current combo drugs to injectable and going through trials would be a waste of time. Any combo drug would bring along it's side effects. Leronlimab mono therapy would be approved in the same timeline as any new combo therapy without the side effects.
Which is why I think this is nonsense and it's not fine with me.
Converting any of the current combo drugs to injectable and going through trials would be a waste of time. Any combo drug would bring along it's side effects. Leronlimab mono therapy would be approved in the same timeline as any new combo therapy without the side effects.
Which is why I think this is nonsense and it's not fine with me.
(0)
(0)
